Health committee  My sense on that—and I'll have to get back to the committee formally—is that the decision on whether or not to reformulate in order to avoid the restrictions is a business decision. There's no requirement in the new marketing rules that would require a business to reformulate. Th

Health committee  Mr. Chair, the rules are not with respect to the formulation of the food. The rules are with respect to what can and can't be marketed. If a firm decides that it wishes to reformulate its product so that it can continue to market, that's a business decision. That's not a require

Health committee  Mr. Chair, I wonder if you might indulge me. I found a figure that Ms. Gladu asked for. I could read it into the record now, which would avoid my writing to the committee later.

Health committee  The figure that the government has put into home care in the current fiscal year is $200 million. The total amount for home care, mental health, and so on is $300 million. That money ramps up over the next 10 years, but the initial amount is $200 million this year.

Health committee  Palliative care would be within the home care amount of $200 million. Thank you.

Health committee  I'm sorry, I'll have to maybe defer that—

Health committee  No, I think that's a question that would be better directed, actually, to the ministry of indigenous services. By order in council—

Health committee  Yes, but by order in council, now the first nations and Inuit health branch is actually no longer the responsibility of Health Canada, and I'm no longer the deputy head responsible for the organization.

Health committee  I'd be answering for a colleague at this point.

Health committee  That would be a question probably better put to parliamentary officials than to bureaucratic officials. What I can say is that we're doing a lot of work to get ready for the eventual deployment of regulations once the bill passes. I would say that I could give assurance to the me

Health committee  The funding we would be providing would be funding that we would be providing, as the minister explained, to provinces and territories. They, in turn, would be making those sorts of allocation decisions.

Health committee  Not that I'm aware of, sir, no.

Health committee  We're doing work with the provinces and territories now to look at issues around a drug formulary. This is obviously a big policy question that all governments have to grapple with, so I can only speak as an official about some of the possible efficiencies. Certainly, there are a

Health committee  I think what I would say to that is that there is a very ambitious agenda. We feel there is very good analytical evidence to suggest that once the measures that have been proposed are in place—and we just had draft regulations gazetted for the Patented Medicine Prices Review Boar

Health committee  I think what would be fair would be to say that developing the changes to the way in which drug pricing is managed in this country, and the way in which purchasing and all the various machinery that's actually involved in the pharmaceutical system.... That's a significant underta